Revolution Medicines Inc.... (RVMDW)
0.09
-0.00 (-4.15%)
At close: Mar 25, 2025, 10:44 AM
-4.15% (1D)
| Bid | 0.07 |
| Market Cap | 17.46M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.09 |
| Volume | 168 |
| Avg. Volume (20D) | 18,676.38 |
| Open | 0.11 |
| Previous Close | 0.09 |
| Day's Range | 0.09 - 0.11 |
| 52-Week Range | 0.09 - 0.11 |
| Beta | 1.46 |
About RVMDW
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies. Its RAS(ON) ...
Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees 534
Stock Exchange NASDAQ
Ticker Symbol RVMDW
Website https://www.revmed.com